243 related articles for article (PubMed ID: 14697745)
21. Mutations in the promoter region of the gene for gp91-phox in X-linked chronic granulomatous disease with decreased expression of cytochrome b558.
Newburger PE; Skalnik DG; Hopkins PJ; Eklund EA; Curnutte JT
J Clin Invest; 1994 Sep; 94(3):1205-11. PubMed ID: 8083361
[TBL] [Abstract][Full Text] [Related]
22. Point mutation in the cytoplasmic domain of the neutrophil p22-phox cytochrome b subunit is associated with a nonfunctional NADPH oxidase and chronic granulomatous disease.
Dinauer MC; Pierce EA; Erickson RW; Muhlebach TJ; Messner H; Orkin SH; Seger RA; Curnutte JT
Proc Natl Acad Sci U S A; 1991 Dec; 88(24):11231-5. PubMed ID: 1763037
[TBL] [Abstract][Full Text] [Related]
23. A novel mutation at a probable heme-binding ligand in neutrophil cytochrome b558 in atypical X-linked chronic granulomatous disease.
Tsuda M; Kaneda M; Sakiyama T; Inana I; Owada M; Kiryu C; Shiraishi T; Kakinuma K
Hum Genet; 1998 Oct; 103(4):377-81. PubMed ID: 9856476
[TBL] [Abstract][Full Text] [Related]
24. Skewing of X-chromosome inactivation in three generations of carriers with X-linked chronic granulomatous disease within one family.
Köker MY; Sanal O; de Boer M; Tezcan I; Metin A; Tan C; Ersoy F; Roos D
Eur J Clin Invest; 2006 Apr; 36(4):257-64. PubMed ID: 16620288
[TBL] [Abstract][Full Text] [Related]
25. Chronic granulomatous disease and glutathione peroxidase deficiency, revisited.
Newburger PE; Malawista SE; Dinauer MC; Gelbart T; Woodman RC; Chada S; Shen Q; van Blaricom G; Quie PG; Curnutte JT
Blood; 1994 Dec; 84(11):3861-9. PubMed ID: 7949143
[TBL] [Abstract][Full Text] [Related]
26. NADPH oxidase activity and cytochrome b558 content of human Epstein-Barr-virus-transformed B lymphocytes correlate with expression of genes encoding components of the oxidase system.
Condino-Neto A; Newburger PE
Arch Biochem Biophys; 1998 Dec; 360(2):158-64. PubMed ID: 9851826
[TBL] [Abstract][Full Text] [Related]
27. Point mutations in the promoter region of the CYBB gene leading to mild chronic granulomatous disease.
Weening RS; De Boer M; Kuijpers TW; Neefjes VM; Hack WW; Roos D
Clin Exp Immunol; 2000 Dec; 122(3):410-7. PubMed ID: 11122248
[TBL] [Abstract][Full Text] [Related]
28. Statistical and mutational analysis of chronic granulomatous disease in Japan with special reference to gp91-phox and p22-phox deficiency.
Ishibashi F; Nunoi H; Endo F; Matsuda I; Kanegasaki S
Hum Genet; 2000 May; 106(5):473-81. PubMed ID: 10914676
[TBL] [Abstract][Full Text] [Related]
29. Third-generation, self-inactivating gp91(phox) lentivector corrects the oxidase defect in NOD/SCID mouse-repopulating peripheral blood-mobilized CD34+ cells from patients with X-linked chronic granulomatous disease.
Roesler J; Brenner S; Bukovsky AA; Whiting-Theobald N; Dull T; Kelly M; Civin CI; Malech HL
Blood; 2002 Dec; 100(13):4381-90. PubMed ID: 12393624
[TBL] [Abstract][Full Text] [Related]
30. p22-phox-deficient chronic granulomatous disease: reconstitution by retrovirus-mediated expression and identification of a biosynthetic intermediate of gp91-phox.
Porter CD; Parkar MH; Verhoeven AJ; Levinsky RJ; Collins MK; Kinnon C
Blood; 1994 Oct; 84(8):2767-75. PubMed ID: 7919388
[TBL] [Abstract][Full Text] [Related]
31. Uncommon missense and splice mutations and resulting biochemical phenotypes in German patients with X-linked chronic granulomatous disease.
Roesler J; Heyden S; Burdelski M; Schäfer H; Kreth HW; Lehmann R; Paul D; Marzahn J; Gahr M; Rösen-Wolff A
Exp Hematol; 1999 Mar; 27(3):505-11. PubMed ID: 10089913
[TBL] [Abstract][Full Text] [Related]
32. PU.1 as an essential activator for the expression of gp91(phox) gene in human peripheral neutrophils, monocytes, and B lymphocytes.
Suzuki S; Kumatori A; Haagen IA; Fujii Y; Sadat MA; Jun HL; Tsuji Y; Roos D; Nakamura M
Proc Natl Acad Sci U S A; 1998 May; 95(11):6085-90. PubMed ID: 9600921
[TBL] [Abstract][Full Text] [Related]
33. Rapid determination of chimerism status using dihydrorhodamine assay in a patient with X-linked chronic granulomatous disease following hematopoietic stem cell transplantation.
Kim HY; Kim HJ; Ki CS; Kim DW; Yoo KH; Kang ES
Ann Lab Med; 2013 Jul; 33(4):288-92. PubMed ID: 23826567
[TBL] [Abstract][Full Text] [Related]
34. Molecular basis of autosomal recessive chronic granulomatous disease in iran.
Teimourian S; de Boer M; Roos D
J Clin Immunol; 2010 Jul; 30(4):587-92. PubMed ID: 20407811
[TBL] [Abstract][Full Text] [Related]
35. X-linked chronic granulomatous disease in a male child with an X-CGD carrier, Klinefelter brother.
Gill HK; Kumar HC; Cheng CK; Ming CC; Nallusamy R; Yusoff NM; Mohamad SB; Ripen AM; Dhaliwal JS; Murad S
Asian Pac J Allergy Immunol; 2013 Jun; 31(2):167-72. PubMed ID: 23859418
[TBL] [Abstract][Full Text] [Related]
36. A 40-base-pair duplication in the gp91-phox gene leading to X-linked chronic granulomatous disease.
Rabbani H; de Boer M; Ahlin A; Sundin U; Elinder G; Hammarström L; Palmblad J; Smith CI; Roos D
Eur J Haematol; 1993 Oct; 51(4):218-22. PubMed ID: 7694872
[TBL] [Abstract][Full Text] [Related]
37. Cloning and sequencing of the bovine flavocytochrome b subunit proteins, gp91-phox and p22-phox: comparison with other known flavocytochrome b sequences.
Davis AR; Mascolo PL; Bunger PL; Sipes KM; Quinn MT
J Leukoc Biol; 1998 Jul; 64(1):114-23. PubMed ID: 9665285
[TBL] [Abstract][Full Text] [Related]
38. Hematologically important mutations: X-linked chronic granulomatous disease (third update).
Roos D; Kuhns DB; Maddalena A; Roesler J; Lopez JA; Ariga T; Avcin T; de Boer M; Bustamante J; Condino-Neto A; Di Matteo G; He J; Hill HR; Holland SM; Kannengiesser C; Köker MY; Kondratenko I; van Leeuwen K; Malech HL; Marodi L; Nunoi H; Stasia MJ; Ventura AM; Witwer CT; Wolach B; Gallin JI
Blood Cells Mol Dis; 2010 Oct; 45(3):246-65. PubMed ID: 20729109
[TBL] [Abstract][Full Text] [Related]
39. Diagnostic Modalities Based on Flow Cytometry for Chronic Granulomatous Disease: A Multicenter Study in a Well-Defined Cohort.
Baris HE; Ogulur I; Akcam B; Kiykim A; Karagoz D; Saraymen B; Akgun G; Eltan SB; Aydemir S; Akidagi Z; Bentli E; Nain E; Kasap N; Baser D; Altintas DU; Camcioglu Y; Yesil G; Ozen A; Koker MY; Karakoc-Aydiner E; Baris S
J Allergy Clin Immunol Pract; 2020; 8(10):3525-3534.e1. PubMed ID: 32736065
[TBL] [Abstract][Full Text] [Related]
40. Long-term correction of phagocyte NADPH oxidase activity by retroviral-mediated gene transfer in murine X-linked chronic granulomatous disease.
Dinauer MC; Li LL; Björgvinsdóttir H; Ding C; Pech N
Blood; 1999 Aug; 94(3):914-22. PubMed ID: 10419882
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
